fashion -WSS

fashion

author：comprehensive 2025-09-07 11:12:27 - browse：4945

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year.

The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was 54.9%, 51.3%, and 51.0% from the lowest to highest doses.

When compared with the 29.7% of patients on placebo who achieved this outcome, the results were statistically significant, according to an abstract of data that will be presented at the annual meeting of the European Association for the Study of the Liver.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Millions may soon lose Medicaid when they don't have to

hotspot

WSS

How the first Native Hawaiian psychiatrist helped diversify medicine

How to fix the rural physician shortage in the U.S.

FDA advisory panel to debate high blood pressure devices

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

People can get long Covid without testing positive for virus: Study

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Drug repurposing or repositioning? The language matters

Novo: Oral version of Ozempic leads to 15% weight loss

Novavax promises a turnaround & Lilly roils the obesity market

CDC says it’s too soon to assess risk posed by Covid subvariant

Medical records are filled with copy

Senate panel passes drug pricing bills, but drops one PBM reform

Drug repurposing or repositioning? The language matters

Kellogg’s is going to war over Mexico’s nutrition label rules

Guidelines to prevent youth baseball injuries need more muscle

Inside the rise of 'mukbang' eating videos

leisure time

Biogen nominates mother of director’s child to replace him on board

Xenotransplantation trials will require adjusting expectations, experts say

Health officials lay out plans to cope with respiratory virus season

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Meadows told special counsel he could not recall Trump ever declassifying Mar

Biogen nominates mother of director’s child to replace him on board

Wikipedia

hotspot

explore

focus